FDA Approved: ROMVIMZA — Original Application (Deciphera Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved ROMVIMZA (vimseltinib) under an Original Application for tenosynovial giant cell tumor, establishing a new treatment option targeting CSF-1R.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tenosynovial Giant Cell Tumor

Drugs mentioned

• ROMVIMZA (vimseltinib)

Snippet

ORIG AP for ROMVIMZA (VIMSELTINIB)